Civatech is developing novel, polymer based brachytherapy devices. Our first product, the CivaString, has been granted FDA 510k clearance.
Civatech Oncology is an emerging medical device company focusing on the development of novel polymer based devices that treat cancer using localized, low-dose-rate radiation.
CivaTech's patented polymer technology enables devices that can be designed and fabricated for specific tumor types. The Company is initially targeting breast, prostate and lung cancer. The approved product is a linear source that meets existing reimbursement codes.